BL
CRBP icon

BFSG LLC’s Corbus Pharmaceuticals CRBP Stock Holding History

BFSG LLC’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10 Hold
1
– – ﹤0.01% 766
2026
Q1 		$10 Hold
1
– – ﹤0.01% 748
2025
Q4 		$9 Hold
1
– – ﹤0.01% 716
2025
Q3 		$13 Hold
1
– – ﹤0.01% 703
2025
Q2 		$7 Hold
1
– – ﹤0.01% 670
2025
Q1 		$6 Hold
1
– – ﹤0.01% 674
2024
Q4 		$12 Hold
1
– – ﹤0.01% 670
2024
Q3 		$21 Hold
1
– – ﹤0.01% 638
2024
Q2 		$46 Hold
1
– – ﹤0.01% 616
2024
Q1 		$40 Sell
1
-60
-98% -$1.48K ﹤0.01% 655
2023
Q4 		$369 Buy
+61
New +$327 ﹤0.01% 588

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

BFSG LLC's CRBP Position: Q2 2026 in Review

BFSG LLC held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 1 share worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #766.

BFSG LLC first reported a position in CRBP in Q4 2023 and has held it in 11 quarters since. The position peaked at $369 in Q4 2023. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • BFSG LLC held 1 share of Corbus Pharmaceuticals worth $10 as of Q2 2026.
  • BFSG LLC left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of BFSG LLC's portfolio in Q2 2026, its #766 holding.
  • BFSG LLC first reported a position in Corbus Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • BFSG LLC's Corbus Pharmaceuticals position peaked at $369 in Q4 2023.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.